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Repeat coronary angioplasty bus become the standard approach
to a first restenosis. However, the long-term outcome of such a
strategy is not well defined . In the present study, 465 patients
(mean age 58 years [range 27 to 791, 53% with multivessel
disease) underwent a second angioplasty procedure at the
same site. The procedure was successful in 96 .8% with a 1 .5%
rate of in-hospital bypass surgery, a 0.9% incidence rate of
myocardial infarction and no procedural deaths . Four hundred
sixty-three patients (99 .6%) were followed up for a mean of
40.5 months. Forty-nine patients (10.6%) underwent a third
angioplasty procedure at the same site, 55 (11
.8%) had coronary
bypass surgery and 33 (7.1%) underwent angioplasty at a
different site
. During follow-up, 12 patients (2.6%) sustained a
myocardial infarction and 21 (4,5%) died including 13 (2 .8%)
with cardiac death . Of the 442 surviving patients, 88% experi-
enced sustained functional improvement and 78% were free
of angina . The actuarial 5-year cardiac survival rate was 96%
and the rate of freedom from cardiac death and myocardial
infarction was 92% .
Even in the second decade of coronary angioplasty experi-
ence, restenosis remains an unresolved problem affecting
about 30% of patients with successful dilation. Restenosis
has a negative impact on the choice of angioplasty as a
revascularization procedure by contributing to diminished
efficacy, increased morbidity and unsatisfactory cost-
effectiveness (1-12) . Although repeat angioplasty at a site of
recurrent stenosis is highly successful and has a low com-
plication rate, the long-term results of such an approach are
not well defined (13-IS) . Thic study reviews the eharacter-
istics and long-term outcome of a group of patients who
underwent one or more angioplasty procedures as treatment
for restenosis .
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For the subgroup of 49 patients who had a third angioplasty
procedure at the same site, the success rate was 93.9% with a 2%
incidence rate of myocardial infarction . There were no in-hospital
deaths or coronary artery bypass operations, The mean follow-up
Interval for this subgroup was 30.5 months with a 22 .4% cross-
over rate to coronary bypass surgery, a 4.1% Incidence rate of
myocardial infarction and a 2% cardiac mortality rate. At last
follow-up, 89% of patients had sustained functional improvement
and 76% were free of angina . The combined angiographic and
clinical restenosis rate was 48% .
Repeat angioplasty as treatment for restenosis Is an effective
approach associated with a high success rate, low incidence
of procedural complications, and sustained functional im-
provement in combination with an acceptable rate of bypass
surgery
. However, there Is a trend toward diminished angloplasty
efficacy after a second restenosis . Thus, decisions for further
revascularixation should be made after careful review of available
options.
(J Am Coll Cardiol 1992,19 :1310-4)
Methods
Study patients
. Review of the Cleveland Clinic Coronary
Angioplasty Registry revealed that of 5,145 patients who
underwent angioplasty between January 1983 and December
1987, 514 (9.4%) underwent repeat angioplasty at the same
site . Forty-nine patients who had a repeat angioplasty pro-
cedure at the same site within 2 weeks of the initial proce-
dure were considered to have had initial angioplasty failure
and were excluded from analysis. The remaining 465 patients
formed the study group
. Clinical and angiographic charac-
teristics, procedural details and complications were obtained
from the Coronary Angioplasty Registry and verified by
chart review .
Definitions
. Extent of coronary artery disease was de-
fined as the number of epicardial vessels (or major branches)
with ?50% lumen diameter stenosis
. Successful balloon
angioplasty was defined as <50% residual stenosis after
angioplasty with a ?20% reduction in the original stenosis
without a major in-hospital complication (death, myocardial
infarction, coronary bypass surgery)
. Restenosis was de-
fined as >_50% lumen narrowing at the site
of the previous
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dilation . The degree of stenosis was assessed by caliper
measurement in the view that demonstrated the maximal
severity of the lesion .
Left ventricular dr .sfanrtien was assessed by contrast
ventriculography and categorized as mild (ejection fraction
46% to 55%)
. moderate (31 % to 45%) or severe (=30%)
.
Unstable angina was dcuned as angina of recent Onset in
the presence of an accelerating pattern, progressive angina
on effort or angina at rest .
Myocardial infarction was defined as a new significant Q
wave or elevation of the crealine kinase MR fraction to
>30 U/liter in association with ST and T wave changes
(non-C, wave)
.
Angioplasty technique . Standard angioplasty techniques
were utilized . Procedural medications included intravenous
heparin . intracoronary or intravenous nitroglycerin . or both .
antiplaielet therapy (aspirin with or without dipyridamolcl
and calcium channel blocking agents . Administration of the
latter agents was continued for ?6 months and nitrates were
administered for m2 days after the procedure . Treatment
with aspirin was continued indefinitely.
Follow-up data. Follow-up data were obtained during
return visits of patients to the hospital . b y
contacting refer-
ring physicians and from interviews with patients by tele-
phone or mail questionnaire . The follow-up questionnaire
included information regarding symptomatic status after
angioplasty, subsequent hospitalization
. coronary angiogra-
phy . occurrence of myocardial infarction. coronary bypass
surgery, repeat angioplasty or death . In particular. patients
were questioned about :h° presence or absence of symptoms
suggestive of angina and categorization of their functional
status as representing improvement. worsening or no change
in comparison with their functional capacity before angio-
plasty .
Statistics . Statistical tests of the distribution of discrete
variables were performed by chi-square or Fisher exact
analysis. Continuous variables were analyzed by Student t
test . Survival analysis wax performed by the Kaplan-Meier
method
.
Results
Baseline characteristics . Four hundred sixty-five patients
(mean age 58 years grange 27 to 791) underwent angioplasty
at a site of recurrent slenosis . Demographic and pertinent
clinical and angiographic data at the time of repeat angio-
plasty are summarized in Table I .
Angioplasty results (Table 2) . During the first angioplasty
procedure, 673 lesions 11 .4lesions/patient) were dilated. At
repeat angioplasty for a first restenosis, 612 lesions were
dilated (1 .3 lesions/patient) including 505 redilated at sites of
restenosis . Three patients presented with an evolving myo-
cardial infarction, and in 27 the previously dilated vessel was
totally occluded. The mean interval from the initial to the
repeat angioplasty procedure was 5 .8 months (range 0 .5 to
40, median 5.0. Repeat angioplasty was performed ?12
months after the initial procedure in 30 patients, including 3
patients who underwent repeat angioplasty 24 to 40 months
after the initial procedure
. The repeat procedure was suc-
cessful in %.8% of patients. Eight of the 15 unsuccessful
procedures involved patients with a totally occluded vessel .
Seven patients (1
.5%I required predischarge coronary by-
pass surgery . which was performed electively in four pa-
tients and as an emergency procedure in three (0 .6%) . The
four 10 .9%) procedure-related myocardial infarctions in-
cluded one Q wave (8 .2%) and three non-Q wave (0.7%)
infarctions . Three of tiese four infarctions were in patients
Table 2 . Results of Angioplasty for a First Restenosis in
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. Subsequent revoscu(uriaotion procedures ibliowir.g repeal
coronary angioplasty (PTCA) for restenosis in 465 I atient5 .
CABG = coronary artery bypass surgery
.
who underwent in-hospital coronary bypass surgery . There
were no procedural deaths .
Fallow-up data . Follow-up data were obtained in 463
patients (99 .6%). The mean follow-up duration was 40
.5
months (range 0.5 to 79) . During follow-up. 125 patients
(27%) required additional revascularization by either angio-
plasty or coronary bypass surgery (Fig . I) . Forty-nine pa-
tients (10 .6%) had a third angioplasty procedure for a second
restenosis at the same site a mean of 7
.3 months, (range I to
36) after the second angioplasty procedure . Thirty-three
patients (7
.1%) had a third angioplasty procedure at one or
more different sites, because of disease progression a mean
of 36 months (range 2 to 73) after the second angioplasty
procedure. Fifty-five patients (11 .8%) required coronary
bypass surgery a mean of 17 months (range 1 .5 to 64) after
the second angioplasty procedure . Overall . revasculariza-
tion was performed for a second restenosis in 84 patients
(18.1%) .
During the follow-up period, 21 patients (4 .5%) died . 13
(2
.8%) of cardiac death . Twelve patients (2.6%) sustained a
Figure 2 . Five-year Kaplan-Meier actuarial freedom from cardiac
death (CD),
myocardial infarciion (MI) and coronary artery bypass
surgery (CABG) in 465 patients undergoing repeat angioplasty or
restenosis .
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Figure 3. Five-year Kaplan-Meier actuarial freedom from cardiac
death
(CD), myocardial infarction (MI). coronary artery bypass
surgery (CABG)L third angioplasty (PTCA) for a second restenosis
and any coronary angioplasty (PTCA) in 465 patients undergoing
repeat angioplasty for restenosis .
SherZ ether
nonfatal myocardial infarction (Q wave in 8 and non-Q wave
in 4) : 3 of these 12 patients had crossed over to coronary
bypass surgery . Figures 2 and 3 show results of Kaplan-
Meier 5-year actuarial cardiac survival analysis and data on
freedom from myocardial infarction, coronary bypass sur-
gery
. a third angioplasty procedure at the same site and an
additional angioplasty procedure at a different site .
At last follotr-up of 442 living patients, 388 (88%) had
sustained functional improvement and 344 (78%) were
free of angina . Of the 385 patients who underwent angio-
plasty as the only means of revascularization, 334 (87%)
reported functional improvement and 301 (78%) were free of
angina .
Angioplasty results and follow-up of the patients with a
third angioplasty procedure for
a second restenosis . Angio-
plasty was successful in 46 (93 .9%) of
49 patients, One
patient (2%) sustained a non-Q wave myocardial infarction .
Two patients with uncomplicated, unsuccessful dilation un-
derwent elective coronary bypass surgery at a later hospi-
talization. There were no procedural deaths . The patients
were followed up for a mean of 30
.5 months (range I to 70).
During follow-up, 2 patients (4
.1%) had a myocardial infarc-
tion and 3(6.1%) died (I of cardiac death) . Eleven (22.4%)
underwent coronary bypass surgery, 3 (6 .1%) had a fourth
angioplasty procedure at the same site and 4 (8
.2%) a
procedure at a different site . In one patient, the third
angioplasty procedure was performed after crossover to
coronary bypass surgery
. At last follow-up, 41 (89%) of the
4, living patients reported sustained functional improvement
3f whom 30 (65 .2%) had angioplasty as the only means of
revascularization . Thirty-five patients (76%) were free
of
angina
; 26 (56 .5%) of these had undergone angioplasty
only .
Twenty-eight (61%) of the 46 living patients had angio-
graphic follow-up : recurrence of stenosis was demonstrated
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in 16 of the 28 (57%) . The six patients without angiographic
follow-up who experienced recurrent angina after a period of
symptomatic relief after angioplasty were also considered to
have restenosis . Thus
. a combined angiugraphic and clinical
restenosis rate of 48% was calculated .
Factors predisposing to a second restenosis . Patients who
had a third angioplasty procedure for a second restenosis did
not differ significantly with regard to age . gender
. hypercho-
lesterolemia, diabetes mellitus . continued smoking . stenosis
before and after angioplasty or vessel dilated from the other
study patients . However . the mean time interval from the
first to the second angioplasty procedure was 3 .6 '_ 2 .4
months for patients who had a second restenosis versus
6 .1 '
4
.9 months for those who did not require a third
revaseularization procedure for a second restenosis (p <
0.0001) .
Discussion
This series represents the largest reported experience of
repeat angioplasty for treatment of restenosis with 463
patients followed up for a mean of 40 .5 months . Although
previous studies (13-15) have shown the safety of repeat
angioplasty for a first restenosis . because of the short
duration of follow-up (mean follow-up times ranged from 8 to
16 months). no solid conclusions could be drawn regarding
the long-term impact of such a strategy .
Coronary restenosis, That restenosis remains the major
limitation of angioplasty needs no emphasis . Several clinical
and anatomic characteristics predisposing to restenosis have
been identified (16)
. These include male gender, diabetes
mellitus (10). hypercholesterolemia (17) . recent or unstable
angina (10,11), previous myocardial infarction (10) . contin-
ued smoking (17) . severity of stenosis before angioplasty
.
residual stenosis and gradient (9,10)
.
absence of intimal tear
(11 .18) . increased lesion length (19) . calcified lesion . eccen-
tricity (9) and left anterior descending artery dilation 111) .
Efforts to combat restenosis with a variety of drugs . includ-
ing aspirin, other platelet inhibitors, coumadin (2,20). cal-
cium channel blockers (3,4) and prednisone (21) . have
been disappointing. Even the much anticipated impact of
mechanical devices such as atherectomy and laser catheters,
aimed at removing atherosclerotic material from the dis-
eased arterial segment, has been at best limited, with initial
reports (22,23) showing recurrent rates of stenosis similar
to those of angioplasty
. Until biologic modulators with
proved effectiveness become part of clinical practice . re-
peat balloon angioplasty will remain the cornerstone of
the nonsurgical approach to restenosis . Use of such an
approach requires careful assessment of several factors :
safety, immediate success and efficacy as judged by impact
on functional status and major events such as death . myo-
cardial infarction . coronary artery bypass surgery and repeat
angioplasty .
Success rate of repeat angioplasty . In the present series .
the success rate was high for repeat angioplasty performed
o1MAS ET AL .
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for a first restenosis (96.8%) and for a third procedure
performed for a second restenosis (93 .944) . Similar success
rates have been reported by other groups (13 .15.211 and
represent a significant improvement over the success rate of
approximately 85% in the earlier (19841 National Heart,
Lung
. and Blood Institute experien .e (14).
Safety. The incidence of myocardial infarction for a
second angioplasty was 0 .06%/c in this series, and the rate of
in-hospital coronary bypass surgery was 1 .5% (0.6% for
emergency bypass surgery)
. In patients requiring a third
angioplasty procedure for a second restenosis, there was a
29% myocardial infarction rate (one non-Q wave infarction)
and no in-hospital bypass surgery was needed. There were
no procedural deaths. Similarly low complication rates have
been reported by Meier et al. (13) and the National Heart,
Lung . and Blood Institute Registry (14).
Efficacy . Efficacy can be viewed as the modification
exerted by a procedure on the natural history of a disease . In
the patient group studied with a53% incidence of multivessel
coronary artery disease . the actuarial 5-yearcardiac survival
rate was 96%
. This high rate reflects the contribution not
only of angioplasty in modifying the natural history of
coronary artery disease, but also of coronary bypass sur-
gery . which was needed in 60 patients (12 .9%) . Neverthe-
less. a strong case can be made for a prudent revasculariza-
tion strategy that allows effective application of angioplasty
as the initial revascularization procedure and recognizes an
important and complementary role for coronary artery by-
pass surgery when multiple restenoses or progression to
more complex forms of disease prevail .
Freedom from major events and restenosis are interre-
lated. If additional angioplasty at any she is excluded from
analysis with the associated angioplasty-related complica-
tions included
. 77% of patients were free of myocardial
infarction, coronary bypass surgery and cardiac death at 5
years
. After adding a third or fourth angioplasty procedure at
the same site . 71% remained event-free at 5 years . Including
angioplasty at any site . 64% of patients remained event-free
at 5 years .
These figures could be amenable to a variety of interpre-
tations depending on one's point of view . However, when
dealing with the treatment of a debilitating and often
progressive disease
. incapacitating symptoms (functional
status) and morbid events (myocardial infarction and death)
are the focus of attention . The need for coronary artery
bypass surgery is an important event that nonetheless
should not be ascribed the negative connotation it has
been traditionally associated with when it is viewed as a
failure of angioplasty strategy . The concept of bypass
surgery and angioplasty as being two complementary
revascularization procedures in the management of patients
with coronary artery disease is not only appropriate, but is
being applied in a rapidly increasing number of patients. In
this regard, at a mean follow-up of 40 .5 months, 88% of
patients had experienced sustained functional improvement,
1314
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whereas the 5-year actuarial morbid event-free survival rate
was 92%.
Third angioplasty for restenosis. The 49 patients who
required a third angioplasty procedure for a second resteno-
sis were followed up for a mean
of
30 .5 months, Three patietds
(6%) required repeat angioplasty at the same site, I I (223)5fI
required coronary bypass surgery and 30 (65 .2%) experienced
sustained functional improvement with angioplasty as the on1
means of revascuimi7alion . The combined angiographic and
clinical reslenosis rate was calcdlated as 47.8% .
Teirstein et al
. (15) have reported the most extensive
experience with a third angioplasty procedure for a second
restenosis . At a mean follow-up interval of 16 months, 64% ;1f
their 74 patients were free of angina attur either a third, fourth
or fifth engioplasty procedure: 27% required coronary bypasss
surgery. The restenosis rate after a third or fourth dilation was
approximately 50% and factors associated with a third resteno-
sis included a shorter time interval between previous engio-
plasty procedures and dilation
of the left anterior descending
coronary artery. In the current study, the only predictor of a
second restenosis was a shorter time interval between the first
and second angioplasty procedures in those patients who
subsequently required a third angioplasty procedure .
The patients who require a third or fourth angioplasty
procedure test the limitations
of the procedure as a viable
alternative in the setting of repeat restenosis, as well as the
ability of the interventional cardiologist to rein his emotions
and let judgment consistently prevail . There are- mixed
feelings among the patients of which disappointment and
frustration are the most prominent . So, multiple restenoses
can be an emotion-laden issue . It is the physician's respon-
sibility to draw the line between a technically feasible versus
an effective procedure integrating available information,
expectation of sustained results and weighing the risks and
benefits of alternate procedures .
Limitations of the present study . Complete angiographic
follow-up
after a second or third angioplasty procedure
would be desirable. However, from a strictly clinical view-
point, the length
of the follow-up period in this study (mean
40.5 months ; temporizes the lack of such information . The
value of diagnostic catheterization procedures for precise
anatomic definition notwithstanding . it is the clinical events
and the patient's functional status that define the efficacy of
any revascularization procedure .
Conclusions
. The current series consists of a large num-
ber of patients followed up
over a long period of lime and
treated according to the prevailing and ever changing trend of
angioplasty practice by various physicians
. When applied
judiciously as treatment for restenosis, angioplasty is an effec-
tive approach
. associated with a high success rate and a low
incidence of
procedural complications, that provides sustained
functional improvement in combination with an acceptable rate
of crossover to coronary artery bypass surgery
. There is a
trend for diminished efficacy after a second restenosis
. There-
fore, decisions for further revascularization should be made
after careful review of available options
.
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